We observed that this combination treatment resulted in enhanced tumor regrowth delay and a significant increase in overall survival compared to cetuximab alone or 8 Gy × 3 fractions of radiation alone (Figure 4G) as well as significantly increased tumor infiltration by CD8+ T cell and NK cells (Figures 4H, I). The gene discussed is CD8A; the disease is neoplasm.